Multaq 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCY3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,469
Award facts
- Contract value 100% obligated
- $36,468.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,468.96 to AmerSourceBergen Drug Corp for 60-count bottles of Multaq 400 mg tablets, a prescription medication used to treat atrial fibrillation. Awarded on January 7, 2026, with an ultimate completion date of January 8, 2026, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to the contractor's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution center for federal medical procurement needs.
This delivery order is issued under AmerSourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031. This strategic vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, syringes, and specialized medical commodities. The DLA Troop Support Medical contract serves critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerSourceBergen as a key pharmaceutical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCY3E?
SPE2DR26FCY3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY3E worth?
The government has obligated $36,469 on SPE2DR26FCY3E.
Is contract SPE2DR26FCY3E an order under another contract?
Yes. SPE2DR26FCY3E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY3E competed?
The extent of competition for SPE2DR26FCY3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award